Summary: The most important enzyme immunoassay techniques are described. The enzymes currently used as labels, the methods of coupling them to antigens or haptens and the possible applications of these assays are reviewed. Furthermore, an overview is given of the reliability and practicability of commercially available enzyme immunoassay kits used in clinical chemical laboratories. Special consideration is given to possible interferences, the detection limits and the mechanization of these tests. Various methods for curve-fitting are listed. It is concluded that most of the currently commercially available enzyme immunoassays are suitable for routine application in appropriate centers like clinical chemical laboratories of larger hospitals. The future role of enzyme immunoassays in clinical chemistry is briefly discussed.
Introduction
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Fig. 2. Principles of heterogeneous enzyme immünoassays (ELISA).
A antigen, E-A enzyme labeled antigen, E-AB enzyme labeled antibody, AB and AB antibody against antigen or hapten under test, AB 2 antibody directed against the immunoglobulin of the species, which was immunized with the antigen to be determined. 
Sandwich antibody assay
classification and schematic representation of the most important assay principles.
Competitive procedures, in which a separation step is avoided, are referred to as homogeneous enzyme immunoassays. In these tests, which are commercially available under the trade name "EMIT"
2 ), the enzymatic activity of the hap ten-enzyme conjugate is influenced by the antigen-antibody reaction (4) . In the first type of these assays ( fig. 1.1 ) the activity of the marker enzyme is reduced, if the hapten-enzyme conjugate is coupled to the antibody.
It is assumed that the antibody reduces the affinity of the substrate to the active site of the enzyme, either by steric hindrance ( fig. 1.1) or by a conformational change of the enzyme, or by prevention of conformational changes necessary for catalytic activity (4, 20, 21, 27) . A further procedure of the EMIT is based on an inhibition of the marker enzyme by the coupled hapten ( fig. 1 .2). The marker enzyme is reactivated, if the antibody to the corresponding hapten is bound to the hapten-enzyme conjugate. So far this technique has only been used for the determination of thyroxine (28) .
With both procedures the enzyme activity determined depends on the concentration of the free hapten in the sample. The technique of the homogeneous enzyme immunoassay is suitable especially for the detection of haptens. Therefore these assays are widely used particularly for drug monitoring and the determination of thyroxine. Recently, however, this principle was also used for the detection of large molecules such as staphylococcal enterotoxin B (29), immunoglobulins (IgG, IgM) and serum albumin (30) .
Other competitive procedures, in which coenzymes are used to label the ligand (5, 6) , may also be classified äs homogeneous enzyme immunoassays. If the ligand-coenzyme conjugate is bound to an antibody, its cycling in a suitable enzymic cycle is proportionally reduced. This inhibition is reversed by unconjugated ligands in competitive binding reactions. The cycling rates are determined by spectrophotometric measurement of a reaction product (5), or of the unbound ligand-cpenzyme conjugate by a highly sensitive bioluminescent reaction employing luciferase (EC 1.2.0.0.) from photobacterium fisheri (6) . So far, however, this assay principle has gained no significance in clinical diagnosis.
Assay systems, in which the enzymic activity of the conjugate is not influenced by the antigen-antibodyreactipn, require a separation step and are called heterogeneous enzyme immunoassays; if solid^phase systems are used for the separation of free and bound labeled molecules, the procedure is called an enzyme-linked immunosorbent assay (ELISA). These procedures allow the determination of haptens and antigens.
The competitive enzyme immunoassay ( fig. 2.1.1 Procedures in which the sample antigen is bound to an enzyme-labeled antibody added in excess, are classified as immuno-enzymometric assays ( fig. 2.2) . The remaining, free labeled antibody is separated by binding with antigen coupled to a solid phase, which is added in excess. In a further procedure, which has also been called a competitive "sandwich" assay (26) , labeled and unlabeled antibody compete for the binding to an antigen, which is bound to an antibody attached to a solid phase ( fig. 2.3 ). This method is used for the detection of antibodies against HB s -antigen (22) . Non-competitive "sandwich" assays have been described in numerous modifications (26) . In the following only the two most common techniques will be briefly explained. In the sandwich antigen assay an excess of antibody is bound to a solid phase ( fig. 2.4.1) . The binding of the antigen to the antibody is determined by use of labeled antibody of the same specificity; therefore, it is necessary that the antigen posses more than one antigenie determinant. Various commercial assays for the detection of HB s -antigen and aj-fetoprotein are based on this technique.
EMIT®: enzyme multiplied immunoassay technique.
In a variation of this method, the bound antibody (ABj) is indirectly labeled by a second enzyme4abeled antl· body, which is directed against the first (AI^) and should not react with the antibody (AB) attached to the solid phase ( fig. 2.4 .2). The antibodies ABi and AB should be obtained from different species. Such an indirect labelling can also be applied to the immunoenzymometric assay. The method of indirect labelling has the advantage, that the corresponding enzyme-antibody conjugates, for a relatively universal application, are commercially available. Thus the often difficult direct labelling of the antibody may be circumvented.
In the sandwich antibody assay, the antibody to be determined reacts with an antigen bound to the solid phase, and is detected by a second enzyme-labeled antibody.
Enzymes used as labels
The quality of an enzyme imrriutioassay depends very much on the purity of the antigen of hapten used for immunization, calibration and conjugation, the specificity of the antibody and the choice of a suitable enzyme label. Sensitive assays require a highly purified enzyme with a high'turnover number, and a low detection limit for the reaction product (22) .
The enzymes listed in table 1 arid 2, which are mainly of vegetable and bacterial origin, have proved generally useful. The enzymes most frequently used so far for heterogeneous enzyme immunoassays are horse-radish peroxidase, alkaline phosphatase and /J-J^galactosidase (tab. 1).
The determination of the enzyme activity is chiefly performed by photometry. In order to increase the Tab. 1. Marker-enzymes for heterogeneous enzyme immunoassays (from data listed in 1. c. (15, 22, (38) (39) (40) detectability of the assays, however, fluorogenic (41, 42,176,177,180), radioactive (43) and chemiluminescence producing substrates (38) are also used. In a newly developed procedure, the activity of peroxidase bound to an antibody-coated membrane is determined by an iodide-sensitive electrode (39).
A thermometric enzyme immunoassay with adequate sensitivity was recently described, in which the enthalpy of the enzyrnic reaction is measured (40). In this assay, a continuous flow system with immobilized antibodies is used. At present this procedure has the disadvantage of a low throughput of 10-20 samples/day and a large specimen volume of 1 ml.
With the homogeneous enzyme immunoassays an NAD dependent glucose-6-phosphate dehydrogenase from Leuconostoc mesenteroides is mainly used. This enzyme can be easily determined photometrically (tab. 2). A turbidimetric procedure is applied for the determination of the activity of lysozyme in the semiquantitative EMIT for the detection of drug abuse (4) . With the newly developed EMIT for the determination of proteins, j3-galactosidase is used as the enzyme label, and a macromolecular chromogenic compound (not further described by the authors) serves as substrate (30) .
Coupling procedures
The choice of a coupling method depends primarily on the molecule to be labeled. Enzyme-antigen or antibody conjugates are usually prepared by glutaraldehyde or periodate methods (22) . The coupling of enzymes to haptens is mostly carried out by formation of a peptide bond between the carboxyl group of a hapten and an amino group of an enzyme by use of the carbodiimide or mixed anhydride method (22) .
Area of application
The area of application of the enzyme immunoassay corresponds largely to that of the radioimmunoassay. Enzyme immunoassays can be performed with samples of serum, plasma, urine and saliva.
For the detection of various drugs and hormones, a number of commercial kits are already used in clinical chemical routine laboratories. Furthermore assays for the determination of plasma proteins, tumor antigens, antigens of pathogenic organisms and antibodies have been developed (22, 26) .
Imprecision
The imprecision of enzyme immunoassays is of the same order of magnitude as that of corresponding radio immunoassays. According to our experience with ·. most of the currently commercially available enzyme immunoassays coefficients of variation from day to day of about 2-10% could be achieved in the medium measuring ränge, if duplicate determinations were performed (tab. 3). However, the use of partly or fully 125 I-labelled digoxin derivatives were used as tracer in all the radioimmunoassay kits. Ref. (84, 165) of Schwarz/Mann yielded comparable coefficients of correlation and regression constants (tab. 4);
In about 2-3% of the specimens tested for digoxin reproducible deviations of more than 30% were found between the results of enzyme-and radioimmunoassays (84) . The cause of these discrepancies is not known. A few authors (85) have reported an unsatisfactory correlation between enzyme-and radioimmunoassays for the determination of digoxin, but most authors have reported a satisfactory correlation (84, (86) (87) (88) (89) (90) (91) 165 ).
The results of the semiquäntitative EMIT for the detection of drug abuse in general agreed sufficiently with those obtained by thin-layer chromatography (92-97), gas-liquid chromatography (92) and a gas-chromatographic-mass-spectrometric method (98) . The efficiency for the detection of barbiturates, amphetamine and various opiates ranged from 75-98% (92, 93, (95) (96) (97) (98) .
Interferences
Enzyme immunoassays may be subject to interferences due to distrubances of the enzymic or immunological reaction.
Endogenous enzymes with similar biological effects to the enzyme used as label, or other factors which directly influence the enzymic reaction, may lead to wrong results.
Thus lysozyme, which is used in the EMIT for the detection of drug abuse, is inhibited by high salt concentrations in urine, various substances like heparin, leucine, phenylalanine and cationic detergents, and by pH-values outside of the range (5.5-8.0) recommended by the manufacturer, all of which can cause false negative results (99,100,172). Conversely, false positive results can be found with this assay, due to an excretion of endogenous lysozyme (101) . Most of these interferences can be avoided by extraction of the specimen with an appropriate organic solvent and subsequent determination of the drug in the reconstituted extract (96, 97, 172 ).
Horse radish peroxidase, an enzyme frequently used as label in heterogeneous enzyme immunoassays, is prone to inactivation by preservatives and other oxidative and reducing agents (171). Therefore, several authors prefer the use of alkaline phosphatase, especially for competitive ELISA type assays (171). With the ELISA-technique, interferences by light absorbing substances, such as hemoglobin, bilirubin or turbidities or by endogenous enzymes or enzyme inhibitors are reduced, if the activity of the bound enzyme conjugate is measured. However, the washing-steps required with this technique may theoretically influence the imprecision of these assays considerably. So far, in most of the homogeneous enzyme immunoassays for quantitative determinations in serum, only a few cases of interference caused by the factors mentioned have been observed. An essential reason for this appears to be the high, about 60 fold, dilution of the serum sample in the reaction medium. Somewhat less favourable conditions are only found with the EMIT for the determination of digoxin (102) or thyroxine (28, 103) . In order to achieve a sufficient detectability with these procedure, the sample is diluted in the reaction medium only 10 and 20 fold respectively. According to the manufacturer of these assays the serum has to be pretreated with 0.5 mol/1 NaOH in order to avoid interferences from certain serum proteins, such as lactate or malate dehydrogenase.
Furthermore interferences can be caused by an unspecific binding of the conjugate to the solid phase, or by certain plasma proteins or transport proteins, which compete with the antibody. Cross-reactions with other compounds occur if the antibody lacks specificity. According to our experience, however, the antibodies of most commercial assays for quantitative determinations show a relatively high specificity (44,46,50, 62, 84). The specificity of the EMIT and heterogeneous enzyme immunoassays (ENZYMUN) for the determination of digoxin corresponds to that of the radioimmunoassay of Schwarz/Mann (tab. 5). Cross-reactions are observed with structurally closely related compounds, such as digitoxin, and various digoxin metabolites, such as digoxigenin, digoxigenin-bis-and digoxigenin-moriodigitoxoside. Canrenone and canrenoate, the major metabolites of spironolactone, apparently do not cause significant interference (84, 89, 104, 105) . In contrast to the enzyme immunoassays for quantitative determinations, most of the semiquäntitative EMIT tests for the detection of drugs in urine show a distinctly lower specificity (92, 93) . Because of possible interferences in these assays, all positive results must be confirmed by a non-immunological method, For clinical toxicölögical routine determinations it has'proved useful Ref. (84, 165) to perform a thin-layer Chromatographie screening test and to use the EMIT as a confirmation analysis (92, 96, 97) . In the detection of barbiturates it was shown that the predictive value for a positive result and the diagnostic specificity were much higher when thin-layer chromatography and EMIT were used sequentially, than when the tests were performed singly or in parallel (106) .
Detection limits
The detectability of the enzyme immunoassay depends on certain variables, such as the assay conditions, the enzyme-substrate combination, the antigen and especially the affinity of the antibody for the antigen (125) body for labeled and unlabeled antigen have an unfavourable effect on the detectability of the assay (107) . Nowadays the limits of detection for the enzyme immunoassay, based on various parameters, are already equal to those of the radioimmunoassay. In general the detection limits of the radioimmunpassays range from 1 -500 pmol/1 or 0.2-50 fm l/ttibe (22) . Comparable detection limits were observed for example with heterogeneous enzyme immunoassays for the determination of HB s -antigen and insulin (tab. 6). A recently described enzyme immunoassay is capable of detecting even 1 attomol of ornitliine-5-aminotransferase (108, 109) . Other assays, for instance for the determination of a^fetoprotein (51,11Ϊ) or digoxin show a detectability which is more than five times lower than that of the corresponding radioimmunoassays (22) . Except for the EMIT digoxin assay, the remaining homogeneous enzyme immunoassays for the determination of drugs show a comparatively low detectability (tab. 6), which, however, *) Where data on the detection limit are not available, the concentration of the lowest calibrator different from zero is quoted instead of the detection limit, which actually may be lower. **) Reagents are not yet commercially available.
is sufficient for the detection of diagnostically relevant serum or urine concentrations of these substances. The advantage of working at a lower detectability is that only very short periods of 30-150 seconds are necessary for the measurement of the enzyme activities. Accordingly in a series of 20 samples the time needed for a determination (incubation periods included) is about 3-6 minutes by EMIT and 10-70 minutes by ELISA type assays (tab. 7). The detectability of homogeneous enzyme immunoassays can be increased, if the reaction of the enzymedrug conjugate with the antibody is stopped after a short time by saturating the antibody with a larger quantity of unlabeled drug (126). 
Mechanization
For routine application, the mechanization of enzyme immunoassays appears to be of great importance (127) .
The homogeneous enzyme immunoassays have very favorable properties for mechanization; all reactants are present in one reaction medium, the time for the measurement of the enzyme activities is short and longer incubation periods are avoided.
So far the analytical systems listed in table 8 have proved useful for the mechanization of the EMIT. Photometers equipped with thermally regulated flow-ceus in combination with suitable dispensers and dilutors, and centrifugal analyzers, are mainly used in partly mechanized procedures. The use of fully mechanized analytical systems for the determination of enzyme activities has to be considered as a further step towards rationalization of these assays. With an Eppendorf system ACP 5040, for example, about 250 patient samples can be analyzed by one technical assistant per day, and the direct costs for technician time and reagents Tab. 8. Mechanized procedures for the performance of EMIT assays. (129, 164) , digoxin (130) Theophylline, thyroxine (131, 132) , phenobarbital, phenytoin (131, 132) , opiates (133) Phenytoin, pheriobarbital, primidone, carbamazepine, digoxin (90, (134) (135) (136) , theophylline (137) Barbiturates, opiates, amphetamine, methadone (138) , phenytoin (79, 139, 140) , phenobarbital (79, 140) , theophylline, primidone, carbamazepine, ethosuximide (79) Phenobarbital (141) Digoxin (45) Phenytoin (142) Thyroxine (76) Phenytoin (64) (159) On principle all calibration curves calculated by a computer should be checked visually. A definitive recommendation of certain curve-fitting methods for enzyme immunoassays cannot be given at present, as extensive comparative studies with these procedures are needed.
Conclusion
Most of the currently commercially available enzyme immunoassays for the determination of haptens, such as various drugs (44, 46, 49, 62, 79, 84, 92, 93) and thyroxine (50, 78), as well as HB s -antigen (81) have already reached a stage of development, in which they appear to be suitable for routine application in appropriate centers, such as the central laboratories of larger hospitals. Despite their ease of operation, however, these assays require certain experience ori the part of the analyst, who must take account of a large number of possible sources of interference. The development of the enzyme immunoassäy is currently still in a state of flux. It has to be expected that the detectability, precision, specificity and practicability of these assays will be further improved. Possible sources of improvement lie in a better standardization of the reagents and methods, the search for more effective marker enzymes and the evaluation of alternative procedures for the determination of enzyme activities, such as fluorimetry, luminescence photometry and thermometry. A far-reaching mechanization of the enzyme immunoassays appears to be essential. According to existing experience, the improvement of the reliability and practicability of these assays by mechanization is likely to be far greater than the beneficial effects of mechanization on the commonly used clinical chemical routine procedures. Furthermore the costs for reagents and technician time can be considerably reduced (44-46, 62,129,150,163,164, 173) , if a suitable mechanization is chosen.
•Recently enzyme immunoassays gained a relatively great expansion in the area of therapeutic drug monitoring, where procedures of a comparable simplicity and specificity were not hitherto available. Using enzyme immunoassays it has now become relatively easy to introduce the monitoring of the serum concentrations of various drugs, and the detection of drugs in urine into the routine program of clinical chemical laboratories. According to our experience there is an increasing demand for such determinations. It has to be assumed that this trend will continue.
Enzyme immunoassays are also increasingly used for the determination of other parameters, such as various hormones, HBg-antigen and antibodies. Further suitable candidates for enzyme immunoassays are enzymes, lipoproteins and bile acids (167-170,181). We believe that iri the future enzyme immunoassays will gain increasing importance in clinical chemistry.
